Korro Bio, Inc. (KRRO) is listed on NASDAQ in the Manufacturing sector. This page tracks real-time KRRO price, technical indicators including RSI, MACD, and the 52-week range, plus fundamentals, earnings history, and recent insider trading activity.
Technical Analysis
RSI (14) 56.9 Neutral
Market Cap $196.7M
Volume 85.2K
Fundamentals — 10-Q Q2 2026
Revenue $0
Net Income $-38.5M
EPS $-2.64
P/E Ratio -5.1x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Aiyar Ram | President and CEO | Sell | 5,802 | $10.84 | $62,917 | 2026 Aug 4 |
| Formela Jean Francois | Insider | Sell | 110,023 | $14.02 | $1.5M | 2026 Jul 6 |
| Formela Jean Francois | Insider | Sell | 171,405 | $14.34 | $2.5M | 2026 Jun 24 |
| Chappell Todd | Chief Operating Officer | Sell | 3,168 | $10.83 | $34,309 | 2026 Jun 16 |
| Vincent Loic A | Chief Scientific Officer | Sell | 3,418 | $10.83 | $37,017 | 2026 Jun 16 |
| Cerio Jeffrey | General Counsel | Sell | 6,609 | $10.83 | $71,575 | 2026 Jun 16 |
| Dolan Oliver | Senior Vice President, Finance | Sell | 3,383 | $10.83 | $36,638 | 2026 Jun 16 |
| Aiyar Ram | President and CEO | Sell | 15,152 | $12.98 | $196,673 | 2026 May 29 |
| Formela Jean Francois | Insider | Sell | 2,860 | $13.95 | $39,897 | 2026 May 28 |
| Lynx1 Capital Management LP | 10% Owner | Buy | 520 | $10.60 | $5,512 | 2026 Mar 31 |
| Yang Rick | Insider | Buy | 207,100 | $11.11 | $2.3M | 2026 Mar 10 |
| Sandell Scott D | Insider | Buy | 207,100 | $11.11 | $2.3M | 2026 Mar 10 |
| New Enterprise Associates 17, L.p. | Insider | Buy | 207,100 | $11.11 | $2.3M | 2026 Mar 10 |
| Chang Carmen | Insider | Buy | 207,100 | $11.11 | $2.3M | 2026 Mar 10 |
| Baskett Forest | Insider | Buy | 207,100 | $11.11 | $2.3M | 2026 Mar 10 |
| Mathers Edward T | Insider | Buy | 207,100 | $11.11 | $2.3M | 2026 Mar 10 |
| Makhzoumi Mohamad | Insider | Buy | 207,100 | $11.11 | $2.3M | 2026 Mar 10 |
| Walker Paul Edward | Insider | Buy | 207,100 | $11.11 | $2.3M | 2026 Mar 10 |
| Florence Anthony A. Jr. | Insider | Buy | 207,100 | $11.11 | $2.3M | 2026 Mar 10 |
| Agarwal Vineet | Chief Financial Officer | Sell | 800 | $70.00 | $56,000 | 2024 Nov 11 |
Take KRRO further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put KRRO in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Korro Bio, Inc. next reports.
Set alerts on KRRO
Get notified when Korro Bio, Inc. hits your price targets or technical conditions are met.
Get Started Free